A Phase 3, Prospective, Double Blinded, Randomized Controlled Trial of the Micronized dHACM Injection as Compared to Saline Placebo Injection in the Treatment of Achilles Tendonitis
Phase of Trial: Phase III
Latest Information Update: 02 Feb 2018
At a glance
- Drugs DHACM (Primary)
- Indications Pain
- Focus Adverse reactions; Therapeutic Use
- Sponsors MiMedx
- 17 Jan 2018 According to a MiMedx media release, the first patients have been enrolled and randomized in in the Orthopedic/Sports Medicine area.
- 17 Jan 2018 Status changed from planning to recruiting, as reported in a MiMedx media release.
- 07 Sep 2017 According to a MiMedx media release, the Company has been notified by the Food and Drug Administration (FDA) that the Investigational New Drug (IND) Phase 3 Achilles Tendonitis clinical study may proceed. The Company expects patient enrollment to commence in the next quarter.